New pill could reduce blood transfusions for thalassemia patients
NCT ID NCT06302491
First seen Mar 02, 2026 · Last updated May 16, 2026 · Updated 11 times
Summary
This study tests an oral drug called AND017 in 64 adults with β-thalassemia, a blood disorder that often requires lifelong transfusions. Participants receive either AND017 or a placebo alongside standard care. The goal is to see if the drug safely raises hemoglobin levels and reduces the need for blood transfusions.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for THALASSEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Guangxi Medical University No.1 Affiliated Hospital
RECRUITINGNanning, Guangxi, 530021, China
Contact
-
Hainan General Hospital
RECRUITINGHaikou, Hainan, 570203, China
Contact
-
Liuzhou People's Hospital
RECRUITINGLiuzhou, Guangxi, 545006, China
Contact
-
Maoming People's Hospital
RECRUITINGMaoming, Guangdong, 525000, China
Contact
-
Nanfang Hospital Southern Medical University
NOT_YET_RECRUITINGGuangzhou, Guangdong, 510515, China
Contact
Conditions
Explore the condition pages connected to this study.